Endurance exercise is an important treatment for people with Parkinson’s disease, Northwestern Medicine research has shown. But is high-intensity or moderate-intensity exercise the most effective in slowing the progression of the disease?
A new Phase 3 multi-site clinical research trial from Northwestern Medicine will test if high-intensity treadmill exercise is more effective in decreasing the signs of Parkinson's disease in individuals who have not initiated medication for Parkinson’s.
This is the first time high-intensity endurance exercise is being studied across a large number of sites in both the U.S. and Canada and in a diverse population.
Read more at: Northwestern University